Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Kostopoulos

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Cancers|November 7, 2020
Deep Phenotyping Reveals Distinct Immune Signatures Correlating with Prognostication, Treatment Responses, and MRD Status in Multiple MyelomaKonstantinos Papadimitriou, Nikolaos Tsakirakis, Panagiotis Malandrakis, et al.
Cells|May 14, 2022
Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response BiomarkerAnastasios I Birmpilis, Antonios Paschalis, Apostolis Mourkakis, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 14, 2020
Next generation flow cytometry for MRD detection in patients with AL amyloidosisEsftathios Kastritis, Ioannis V Kostopoulos, Foteini Theodorakakou, et al.
Basic Research in Cardiology|March 23, 2024
Early microvascular coronary endothelial dysfunction precedes pembrolizumab-induced cardiotoxicity. Preventive role of high dose of atorvastatinPanagiotis Efentakis, Angeliki Choustoulaki, Grzegorz Kwiatkowski, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 1, 2021
Consolidation with a short course of daratumumab in patients with AL amyloidosis or light chain deposition diseaseEfstathios Kastritis, Pantelis Rousakis, Ioannis V Kostopoulos, et al.
Free Radical Biology & Medicine|February 14, 2021
Acute administration of the olive constituent, oleuropein, combined with ischemic postconditioning increases myocardial protection by modulating oxidative defenseMaria Tsoumani, Anastasios Georgoulis, Panagiota-Efstathia Nikolaou, et al.
Transfusion|June 6, 2026
Acute pain transfusion reaction in a patient with thalassemia: In-depth characterization of short- and long-term phenotypesGeorgia Tzafa, Sophia Delicou, Ioanna Barla, et al.
Hemasphere|January 25, 2020
Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline TherapyEvangelos Terpos, Ioannis V Kostopoulos, Efstathios Kastritis, et al.
American Journal of Hematology|June 11, 2024
Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myelomaIoannis V Kostopoulos, Ioannis Ntanasis-Stathopoulos, Pantelis Rousakis, et al.
Blood|January 11, 2022
Systems medicine dissection of chr1q-amp reveals a novel PBX1-FOXM1 axis for targeted therapy in multiple myelomaNikolaos Trasanidis, Alexia Katsarou, Kanagaraju Ponnusamy, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Cancers|November 7, 2020
Deep Phenotyping Reveals Distinct Immune Signatures Correlating with Prognostication, Treatment Responses, and MRD Status in Multiple MyelomaKonstantinos Papadimitriou, Nikolaos Tsakirakis, Panagiotis Malandrakis, et al.
Cells|May 14, 2022
Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response BiomarkerAnastasios I Birmpilis, Antonios Paschalis, Apostolis Mourkakis, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 14, 2020
Next generation flow cytometry for MRD detection in patients with AL amyloidosisEsftathios Kastritis, Ioannis V Kostopoulos, Foteini Theodorakakou, et al.
Basic Research in Cardiology|March 23, 2024
Early microvascular coronary endothelial dysfunction precedes pembrolizumab-induced cardiotoxicity. Preventive role of high dose of atorvastatinPanagiotis Efentakis, Angeliki Choustoulaki, Grzegorz Kwiatkowski, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 1, 2021
Consolidation with a short course of daratumumab in patients with AL amyloidosis or light chain deposition diseaseEfstathios Kastritis, Pantelis Rousakis, Ioannis V Kostopoulos, et al.
Free Radical Biology & Medicine|February 14, 2021
Acute administration of the olive constituent, oleuropein, combined with ischemic postconditioning increases myocardial protection by modulating oxidative defenseMaria Tsoumani, Anastasios Georgoulis, Panagiota-Efstathia Nikolaou, et al.
Transfusion|June 6, 2026
Acute pain transfusion reaction in a patient with thalassemia: In-depth characterization of short- and long-term phenotypesGeorgia Tzafa, Sophia Delicou, Ioanna Barla, et al.
Hemasphere|January 25, 2020
Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline TherapyEvangelos Terpos, Ioannis V Kostopoulos, Efstathios Kastritis, et al.
American Journal of Hematology|June 11, 2024
Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myelomaIoannis V Kostopoulos, Ioannis Ntanasis-Stathopoulos, Pantelis Rousakis, et al.
Blood|January 11, 2022
Systems medicine dissection of chr1q-amp reveals a novel PBX1-FOXM1 axis for targeted therapy in multiple myelomaNikolaos Trasanidis, Alexia Katsarou, Kanagaraju Ponnusamy, et al.
Pageof 6